Kestra Medical Technologies, Ltd.
KMTS
$27.90
-$0.45-1.59%
NASDAQ
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -13.67% | -4.21% | -26.95% | 50.39% | -142.01% |
| Total Depreciation and Amortization | 17.25% | -16.43% | 17.01% | 10.46% | -2.75% |
| Total Amortization of Deferred Charges | -0.21% | 0.21% | -0.21% | 27.10% | 117.06% |
| Total Other Non-Cash Items | 10.32% | 3.14% | 258.70% | -88.99% | 1,420.40% |
| Change in Net Operating Assets | 133.03% | 197.61% | 111.89% | -234.51% | -396.67% |
| Cash from Operations | -1.93% | -0.13% | 30.19% | -9.22% | -33.67% |
| Capital Expenditure | 3.21% | -33.15% | 9.30% | -11.49% | -65.08% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3,205.11% | -6,266.25% | 116.22% | 184.62% | -69.77% |
| Cash from Investing | -1,057.62% | -101.06% | 9.86% | -11.18% | -66.38% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.60% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -613.76% | -303.70% | 98.56% | 45.81% | -2,807.56% |
| Cash from Financing | -100.12% | 552,625.93% | 98.56% | -100.87% | 180,522.69% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -265.33% | 549.39% | 29.11% | -119.85% | 912.03% |